Compare Charles River Laboratories Intl. Inc (CRL) vs Fubotv Inc (FUBO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Fubotv Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $283 (market cap $13.58B), while Fubotv Inc trades at $9.85 (market cap $1.06B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 12.8× Fubotv Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Fubotv Inc nearer its low. Which is the better fit depends on your goals.
| CRL | FUBO | |
|---|---|---|
Market Cap | $13.58B | $1.06B |
Sector | Health | Technology |
52-Week High | $284.37 | $54.72 |
52-Week Low | $145.57 | $8.09 |
Enterprise Value | $16.41B | $1.23B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $281.27, near its 52-week high, with a slight 0.26% decline. The stock shows bullish technical signals, including strong moving averages, despite overbought RSI readings. Recent Q2 2026 earnings beat estimates with EPS of $3.02 versus $2.74 expected, and the company raised full-year guidance, reflecting improved biotech demand. However, fundamentals reveal challenges, with a negative net income margin of -5.96% and elevated P/E ratio of 684.85, indicating high valuation relative to profitability.
Outlook: CRL benefits from positive analyst sentiment (72% buy ratings) and institutional accumulation, but risks include profitability pressures, high debt, and reliance on biotech sector health. The consensus price target of $277.29 suggests limited upside, urging caution despite operational improvements.
FUBO trades at $9.80, up 1.03% with a bullish technical signal and improving fundamentals. The stock shows strong valuation metrics with P/E of 2.53 and P/S of 0.19, while recent earnings beat expectations in Q1 and Q2 2026. Revenue grew to $1.62B in 2024 with net income margin improving to 7.61% in 2025 projections. Analyst consensus is bullish with a $15.33 price target and no sell ratings among 15 analysts covering the stock.
FUBO presents a compelling turnaround story with improving profitability and attractive valuation. The company's partnership with Disney/Hulu and sports content focus drives growth potential, though negative cash flow and high debt levels remain concerns. With 47% analyst buy ratings and 53% upside to consensus target, the stock offers significant potential if execution continues improving.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Fubotv Inc
FuboTV Inc is a sports-first, live TV streaming company, offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, fuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. The company offer subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality best suited to their preferences. The operating segments of the group are Streaming and Online wagering, of which a majority of revenue is derived from the Streaming segment. It has a business presence in the U.S. and other international countries.
Read more on FUBO →
